Pantoprazol Vir (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Vir, is a proton pump inhibitor presented as an oral formulation for oral use. It reduces gastric acid secretion and is used to manage acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and NSAID‑induced gastric ulcers.

GNH USA supplies Pantoprazol Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide, ensuring quality and regulatory compliance across markets. The product meets European Union standards for safety and efficacy.

Pantoprazole is a proton pump inhibitor used to treat conditions caused by excess gastric acid.

- Gastroesophageal reflux disease (GERD): reduces acid exposure and relieves heartburn and regurgitation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Zollinger‑Ellison syndrome: controls hypergastrinemia‑driven acid hypersecretion. - NSAID‑induced gastric ulcer: protects the gastric mucosa by lowering acid output.

Pantoprazol Vir may cause adverse reactions, which are categorized by frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of queasiness, often transient. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Low magnesium levels: muscle cramps, weakness, or arrhythmias. - Liver enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin blistering. - Pancreatitis: upper abdominal pain with elevated enzymes.

When prescribing Pantoprazol Vir, consider the following precautions.

- Renal function assessment: adjust use in severe renal impairment. - Infection monitoring: watch for signs of gastrointestinal infections. - Bone health evaluation: long‑term use may affect calcium absorption. - Elderly patients: start with the lowest effective dose. - Discontinuation guidance: avoid abrupt cessation after prolonged therapy. - Store at room temperature: keep in the original container, protect from moisture.

Pantoprazol Vir can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Atazanavir: reduced antiviral absorption. - Clopidogrel: decreased antiplatelet effect. - Warfarin: potential alteration of anticoagulation. - Methotrexate: increased toxicity risk. - Digoxin: altered serum concentrations.

Moderate Interactions (Monitor Closely): - Phenytoin: reduced plasma levels. - Carbamazepine: decreased efficacy. - Fluconazole: increased pantoprazole exposure. - Ketoconazole: reduced antifungal absorption. - Cimetidine: additive acid suppression.